c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis
作者： Shan Yu , Yiyi Yu , Naiqing Zhao , Jianlan Cui , Wei Li
DOI: 10.1371/JOURNAL.PONE.0079137
关键词:
摘要: Background c-Met has been recognized as an important therapeutic target in gastric cancer, but the prognostic property of c-Met status is still unclear. We aimed to characterize effect by systematic review and meta-analysis.
harvard.edu
core.ac.uk 
sci-hub.se 参考文章(32)
Yuji Toiyama, Hiromi Yasuda, Susumu Saigusa, Kouhei Matushita, Hiroyuki Fujikawa, Koji Tanaka, Yasuhiko Mohri, Yasuhiro Inoue, Ajay Goel, Masato Kusunoki, Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. International Journal of Cancer. ,vol. 130, pp. 2912- 2921 ,(2012) , 10.1002/IJC.26330
Hiroki Kuniyasu, Wataru Yasui, Yasuhiko Kitadai, Hiroshi Yokozaki, Hisao Ito, Eiichi Tahara, Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochemical and Biophysical Research Communications. ,vol. 189, pp. 227- 232 ,(1992) , 10.1016/0006-291X(92)91548-5
Daniel V.T. Catenacci, Gustavo Cervantes, Soheil Yala, Erik A. Nelson, Essam El-Hashani, Rajani Kanteti, Mohamed El Dinali, Rifat Hasina, Johannes Brägelmann, Tanguy Seiwert, Michele Sanicola, Les Henderson, Tatyana A. Grushko, Olufunmilayo Olopade, Theodore Karrison, Yung-Jue Bang, Woo Ho Kim, Maria Tretiakova, Everett Vokes, David A. Frank, Hedy L. Kindler, Heather Huet, Ravi Salgia, RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma Cancer Biology & Therapy. ,vol. 12, pp. 9- 46 ,(2011) , 10.4161/CBT.12.1.15747
Seung Yi, Ming-Sound Tsao, Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Neoplasia. ,vol. 2, pp. 226- 234 ,(2000) , 10.1038/SJ.NEO.7900080
Mahesh K. B. Parmar, Valter Torri, Lesley Stewart, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine. ,vol. 17, pp. 2815- 2834 ,(1998) , 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
Y Yonemura, N Nojima, M Kaji, T Kawamura, S Fushida, T Fujimura, H Itoh, H Fujita, J Miyazaki, Y Endou, T Sasaki, H Yamamoto, E-cadherin and c-met expression as a prognostic factor in gastric cancer. Oncology Reports. ,vol. 4, pp. 743- 748 ,(1997) , 10.3892/OR.4.4.743
Paolo Conrotto, Donatella Valdembri, Simona Corso, Guido Serini, Luca Tamagnone, Paolo Maria Comoglio, Federico Bussolino, Silvia Giordano, Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood. ,vol. 105, pp. 4321- 4329 ,(2005) , 10.1182/BLOOD-2004-07-2885
Ahmedin Jemal, Freddie Bray, Melissa M. Center, Jacques Ferlay, Elizabeth Ward, David Forman, Global cancer statistics CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 69- 90 ,(1999) , 10.3322/CAAC.20107
Arnulf H Hölscher, Stefan P Mönig, Paul M Schneider, Stephan E Baldus, Hans P Dienes, Monika F Retterspitz, Stephanie Schreckenberg, Expression of β-Catenin, MUC1 and c-Met in Diffuse-type Gastric Carcinomas: Correlations with Tumour Progression and Prognosis Anticancer Research. ,vol. 30, pp. 4635- 4641 ,(2010)
Jeeyun Lee, Jin Won Seo, Hyun Jung Jun, Chang-Seok Ki, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Min Gew Choi, Jae Moon Bae, Tae Sung Sohn, Jae Hyung Noh, Sung Kim, Hey-Lim Jang, Ji-Youn Kim, Kyoung-Mee Kim, Won Ki Kang, Joon Oh Park, Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncology Reports. ,vol. 25, pp. 1517- 1524 ,(2011) , 10.3892/OR.2011.1219